Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Celldex Therapeutics shares fall after company announces offering price of $3.15 per share
Yahoo/AP
Wednesday, May 18, 2011 - 6:35pm
tags:
Celldex, Pfizer, stock offering
Avandia — When A Drug Is On The Market, But Not Really
Forbes
Wednesday, May 18, 2011 - 6:34pm
tags:
diabetes, Avandia, GSK
Aeterna Zentaris posts better sales, but greater costs lead to wider 1st-quarter loss
Yahoo/AP
Wednesday, May 18, 2011 - 6:34pm
tags:
earnings, Aeterna Zentaris
11 Potential Biotech Buy Out Targets
Seeking Alpha
Wednesday, May 18, 2011 - 11:50am
tags:
M&A, Alexion, Celgene, Biogen Idec, Celldex, Geron, Illumina, Micromet, Mylan, Vical, Oncothyreon, Pharmasset
Roche cancer programs angle for a starring role at ASCO
Fierce Biotech
Wednesday, May 18, 2011 - 11:46am
tags:
Roche, ASCO, skin cancer, Plexxikon
ISTA Sues FDA Over Generic XIBROM Approval, Says ANDA Approval Should Disappear in the Blink of An Eye
FDA Law Blog
Wednesday, May 18, 2011 - 11:44am
tags:
Ista, generics, FDA, Xibrom, Coastal Pharmaceuticals
Cytrx: Another Stride Ensuring Continued Shareholder Value
Seeking Alpha
Wednesday, May 18, 2011 - 11:43am
tags:
CytRx, Orphazyme
Nikkei says Nycomed buyout imminent; Takeda says no
Fierce Pharma
Wednesday, May 18, 2011 - 11:41am
tags:
M&A, Takeda, Nycomed
Pfizer Blames Teva, Ivax for ’Billions’ in Neurontin Losses
Bloomberg
Wednesday, May 18, 2011 - 11:36am
tags:
Ivax Diagnostics, Teva Pharmaceuticals, Neurontin, Pfizer, generics, epilepsy
Targacept's $75M Stock Offering Targets Cognitive Disorders R&D
Motley Fool
Wednesday, May 18, 2011 - 11:29am
tags:
AstraZeneca, Targacept, stock offering, R&D, schizophrenia
Shire swoops to buy Advanced BioHealing
Pharma Times, UK
Wednesday, May 18, 2011 - 11:23am
tags:
Advanced BioHealing, Shire, M&A, diabetic foot ulcers, regenerative medicine
Novartis: Dividend Stock Analysis
Seeking Alpha
Wednesday, May 18, 2011 - 11:20am
tags:
dividends, Novartis
Are You Missing Something Easy at Eli Lilly?
Motley Fool
Wednesday, May 18, 2011 - 11:19am
tags:
Eli Lilly
Higher Doses of Pfizer Alzheimer’s Drug Trigger Ban Request
Bloomberg
Wednesday, May 18, 2011 - 11:18am
tags:
Pfizer, Alzheimer's disease, Aricept, Eisai
Swiss Daybook: Takeda for Nycomed, Roche, Novartis, Syngenta
Bloomberg
Wednesday, May 18, 2011 - 11:17am
tags:
Takeda, Roche, Novartis, Nycomed
Drug Spending Growth Drops as Brands Are Replaced by Generics
Bloomberg
Wednesday, May 18, 2011 - 11:16am
tags:
generics, IMS, prescription data
Analysts Estimate Johnson & Johnson Can Outperform Pfizer Over Next 5 Years
Seeking Alpha
Tuesday, May 17, 2011 - 8:53pm
tags:
Pfizer, JNJ
Epilepsy Drug Study Showing Little Risk May Help Vivus Pill
Bloomberg
Tuesday, May 17, 2011 - 8:53pm
tags:
Vivus, epilepsy, Qnexa
AstraZeneca: The Street Is too Pessimistic on This High Dividend Big Pharma Stock
Seeking Alpha
Tuesday, May 17, 2011 - 8:52pm
tags:
AstraZeneca, GSK, Merck, Bristol-Myers Squibb
CytRx touts "game changing" $120M pact with Orphazyme
Fierce Biotech
Tuesday, May 17, 2011 - 1:08pm
tags:
Orphazyme, CytRx

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.